SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006582
Filing Date
2021-05-10
Accepted
2021-05-10 08:28:25
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20210331x10q.htm   iXBRL 10-Q 1932091
2 EX-31.1 vygr-20210331xex31d1.htm EX-31.1 12994
3 EX-31.2 vygr-20210331xex31d2.htm EX-31.2 13013
4 EX-32.1 vygr-20210331xex32d1.htm EX-32.1 10731
5 GRAPHIC vygr-20210331x10q006.jpg GRAPHIC 54860
  Complete submission text file 0001558370-21-006582.txt   6876639

Data Files

Seq Description Document Type Size
6 EX-101.SCH vygr-20210331.xsd EX-101.SCH 43398
7 EX-101.CAL vygr-20210331_cal.xml EX-101.CAL 48878
8 EX-101.DEF vygr-20210331_def.xml EX-101.DEF 157536
9 EX-101.LAB vygr-20210331_lab.xml EX-101.LAB 400645
10 EX-101.PRE vygr-20210331_pre.xml EX-101.PRE 295360
11 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20210331x10q_htm.xml XML 1156973
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 21905356
SIC: 2836 Biological Products, (No Diagnostic Substances)